obese-hyperglycemic syndrome develops in all mice homozygous for the gene ob/ob (70). The most distinguishing features of the syndrome are similar to those found in obese human diabetics and include the excessive deposition of body fat, as well as a moderate degree of hyperglycemia in the presence of hyperinsulinemia (10, 62). The reason for the elevated glucose in the presence of high insulin levels is not clearly understood.
Since the immunoreactive insulin of the obese mouse has been shown to be biologically active (62), the focus of attention has been placed on the existence of a tissue resistance to insulin. It has been shown that the obese mouse can tolerate large doses of exogenous insulin without becoming hypoglycemic (6, 41) . In vitro studies have demonstrated that skeletal muscle from obese mice does not respond to insulin added at concentrations that elicit a marked response in muscle from lean mice (1, 6, 41) . A similar resistance to insulin has been found in vitro in adipose tissue from obese mice (1, 6)*
It is unclear what role the liver plays in the hyperglycemia of the obese mouse. Studies in vitro have reported hepatic gluconeogenesis to be both increased (55) and not different (11) from that in lean mice. Studies of hepatic enzyme activity have shown that both gluconeogenic and glycolytic enzymes are elevated in the obese mouse, thus leaving in doubt whether net hepatic (7, 57 ).
glucose production is altered
To study the role of liver in the control of blood glucose, advantage has been taken of the rapid adaptation of hepatic metabolism, in normal man and animals, to the administration of a glucose load. In response to the administered glucose and the associated release of insulin, there is a rapid decrease in hepatic glucose production (5, 8, 19, 20, 22, 63, 68) . In addition, a significant percent of the administered glucose load is taken up and stored by the liver as glycogen (5, 32) . The rate of glycogenesis is closely correlated with the activity of the enzyme glycogen synthetase (UDPglucose: a-1 ,4-glucan-ol-4-glucosyltransferase [EC 2.4,l. 111) (27, 29, 35). Glycogen synthetase exists in liver in at least two forms that are interconvertible by a phosphorylation-dephosphorylation reaction sequence (17, 46). The dephosphorylated form represents the physiologically active species of the enzyme under in vivo conditions (2, 27, 29, 35, 46). This form has been termed synthetase I (glucose-6-phosphate (G-6-P) independent) (17, 29) because it exhibits activity in the absence of G-6-P or synthetase a (27, 46) because of its greater affinity for both 'UDPgIucose and G-6-P. The amount of glycogen synthetase present at any time as synthetase I is under the control of humoral (2, 27, 35), neural (59, 6.0), and substrate availability (4 In each case 1 ml of column effluent was placed in 10 ml of Aquasol for radioactivity determination* Glycogen was extracted from liver by digestion of a ZOOmg portion of tissue in 0.4 ml of 30 % KOH followed by precipitation of the glycogen with 0.1 ml of 4 % Na$SOd and 1.2 ml of 95 % ethanol. The glycogen pellet was washed 3 times by being dissolved in water followed by reprecipitation with NazSO4 and ethanol-The final pellet was dissolved in 0.5 ml of water. One aliquot was removed and hydrolyzed to glucose with 1 IN HCl (90°C for 2 h) for the determination of total hepatic glycogen content expressed as glucose units.
[14C]glycogen was determined in another aliquot (0.1 ml) that was mixed with 1 ml of Nuclear-Chicago solubilizer at 20°C for 16 h followed by the addition of 10 ml of Spectrafluor.
All Alanine was determined in 1 ml of a reagent mixture containing 100 pm01 K-phosphate buffer, pH 7.5; I pmol cr-ketoglutaratc; 0.004 pmol ,IjADH; 0.3 IU lactic dehydrogenase; and 0.6 IU glutamic pyruvic transaminase. Aspartate was measured in a similar reagent mixture in which the enzymes used were 1 .O IU malate dchydrogenase and 0.5 IU glutamic oxalacetic transaminase. Glycogen synthetase activity was determined as previously described (35). The reaction was carried out at 37°C rather than 25°C since the activity was greater at the higher temperature and enzyme instability was not encountered (30). The glycogen synthetase activating system (synthetase D phosphatase) was determined by modification of the method of Hizukuri and Larner (28). A ZOO-mg portion of freshly removed liver was homogenized in 1 ml of cold reagent containing: 30 pmol Tris-HCl, pH 7.2, 2 pmol EDTA, 300 pmol sucrose, and 20 pmol sodium sulfite, with or without the addition of 10 pmol MgClz (2). The homogenate was centrifuged at 1,000 X g for 15 min at 2°C. An aliquot of the supernatant was removed at zero time for determination of glycogen synthetase activity (*G-6-P). The remaining supernatant was incubated at ZO"C, and aliquots were removed at 1 h and 3 h for glycogen synthetase determination.
The decrease in synthetase I (-G-6-P) with time is a measure of synthetase D phosphatase activity.
Chemicals. A P value less than 0.05 was considered a significant difference.
RESULTS
Plasma ghost and insulin Zecels. The hyperglycemia and hyperinsulinemia of the obese mouse compared with its lean littermate are shown in Table 1 . Plasma glucose and insulin levels were elevated in obese mice bled prior to (0 min) and 30 min after the administration of glucose. The significant insulin response to the administration of glucose is consistent with the report of Westman (71), indicating that there is no delay in the insulin secretory response of obese mice to glucose. The complete glucose tolerance curve is shown in Fig. 1 . Compared with lean mice, the blood @ucose in obese mice attained a greater peak concentration and failed to return to fasting values for at least 2 h after glucose administration.
Gluconeogenesis from ['"Cl I a anine in Ienn and obese mice. Hepatic levels of gluconeogenic intermediates. The hepatic con- Hepatic gljcogen synthetase activity in lean and obese mice. In normal man and animals a significant percent of an orally administered glucose load is deposited as liver glycogen. The rate of glycogenesis has been closely correlated with the activity of glycogen synthetase in the I (G-6-P independent) form. Figure 4 shows the activity of this enzyme at various times after the oral administration of glucose to fasted lean and obese mice. total glycogen synthetase activity (measured in the presence of 10 mM G-6-P) and the height of the hatched portion indicates synthetase I activity. Within 15 min after glucose administration to lean mice there was a fourfold increase in synthetase I, with no change in total synthetase activity. Synthetase I remained elevated at 30 and 60 min and returned to fasting values at 120 min. Although total synthetase activity did tend to increase somewhat (significant at 60 and 120 min), this has not been seen in other similar experiments.
In obese mice the administration of an oral glucose load did not result in a significant increase in synthetase I activity. In fact, there was a transient, but significant, decrease at 15 min. Total synthetase activity did not change at any time period.
Mixing crude liver preparations from lean and obese mice indicated that failure to detect an increase in synthetase I in obese mice was not due to the presence of an endogenous inhibitor.
Further evidence for the activation of glycogen synthetase after glucose and an increased metabolite flux through this step in lean but not obese mice is presented in Table 3 . The levels of the substrate (UDPglucose) and product (glycogen) of the synthetase reaction were measured in livers from mice killed after glucose administration.
In lean mice, consistent with the increase in synthetase I, there was a marked decrease in the level of UDPglucose at 15-60 min after glucose ingestion. At 120 min the UDPglucose level returned to the control value. In addition, in lean mice there was an increase in hepatic glycogen level that was statistically significant at 60 and 120 min. In obese mice, except for a transient decrease at 60 min, the level of UDPglucose was not altered by glucose ingestion.
Although fasted obese mice (0 min) did have a greater hepatic glycogen content than their lean littermates, there was no increase in glycogen content due to the administration of a glucose load. The conversion of glycogen synthetase from its inactive (synthetase D) to its active (synthetase I) form is catalyzed by synthetase D phosphatase (17)* The synthetase-activating system is absent from alloxan-diabetic rats and accounts for the inability of these animals to increase their synthetase I activity when given glucose (24). The existence of this activating system in liver from lean and obese mice was determined by the increase in the amount of synthetase I during the in vitro incubation of a crude liver homogenate (28). Preliminary studies indicated that the increase in synthetase I was not due to the formation of G-6-P in the crude homogenate.
The reaction was conducted in the presence and absence of Mg++ to detect both Mg++-independent and total synthetase D phosphatase (2). Figure 5 shows the time course of the increase in synthetase I (expressed as a percent of total glycogen synthetase) in livers from lean and obese mice. In livers from both lean and obese mice the presence of synthetase D phosphatase was clearly evident. In 3 h of incubation the percent synthetase 1 in liver from lean mice increased from 39 to 64 % and from 39 to 57 % in the presence and absence of Mg++, respectively. Similar increases were seen in livers from obese mice. The slow rate of synthetase I formation is similar to the 4O-to 60-min lag period reported by Gold (24) in livers of fasted mice. In addition, the substrate for this activating system is the phosphorylated form of glycogen synthetase (synthetase D). Since we used synthetase D present in the crude liver homogenate instead of a purified substrate preparation, our data can be taken only as qualitative and not quantitative evidence of the presence of synthetase D phosphatase.
Comparison of response to oral and intraperitoneal glucose. It is known that certain gastrointestinal hormones, which are released in response to the oral ingestion of glucose, can modulate the pancreatic secretion of insulin and glucagon (66). To eliminate this factor as a cause of the abnormal response in the obese mouse, we compared the response of glycogen synthetase to glucose administered orally with that administered intraperitoneally. The results shown in Table 4 indicate that obese mice failed to activate glycogen synthetase (increase in percent of synthetase I) in response to glucose given by either route. The glucose given by either route produced the same increase in hepatic glucose concentration. Lean mice activated glycogen synthetase equally in response to glucose given by either route. The higher synthetase I content in lean compared with obese mice occurred despite a lower hepatic glucose concentration.
DISCUSSION
The liver plays a major role in maintaining the level of blood glucose within the normal physiological range. It functions primarily to synthesize glucose from three-carbon precursors (gluconeogenesis) in time of need (fasting) and store glucose as glycogen after a carbohydrate meal. Humoral and neural factors, as well as substrate availability, determine which hepatic function will predominate. The genetic obese-hyperglycemic mouse (C57 BL/GJ-ob) exhibits a moderate hyperglycemia in the presence of a marked hyperinsulinemia (10, 62). Often after a 24-h fasting period the obese mouse has normal or only slightly elevated blood glucose, but responds to a glucose load with an exaggerated hyperglycemia (Fig. 1) . Since insulin levels are markedly elevated at all times during the glucose tolerance test, the concept of a tissue resistance to insulin has been suggested as the cause of the hyperglycemia.
Insulin resistance in obese mice has been clearly demonstrated for skeletal muscle (1, 6, 41 ) and adipose tissue (1, 6) ; this paper prcsents in vivo evidence that insulin resistance may extend to hepatic tissue as well.
The measurement of gluconcogenesis in vivo from the incorporation of radioactivity of 14C-labeled precursors into glucose is subject to complications (19 when it was given a glucose load sufficient to produce insulin release and transient hyperglycemia (Fig. 2) . The time course of the suppressed gluconeogenesis coincided with the period of elevated blood glucose.
In lean mice the incorporation of label into glucose and hepatic glycogen from [14C]glycerol markedly exceeded that from [14C]alanine.
In addition, gluconeogenesis from ['"Clglycerol was not suppressed by the administration of glucose (Table  2) . Glycerol is known to enter the gluconeogenic pathway at the triose phosphate step, whereas alanine is first transaminated to pyruvate and then, through a sequence of enzymic steps, converted to the triose phosphates (13, 6 1 
